摘要:
elsevier.com
sci-hub.se 参考文章(9)
Arthur Rook, Textbook of dermatology ,(1968)
Janet Pope, D Fenlon, A Thompson, Beverley Shea, Dan Furst, George A Wells, Alan Silman, Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis Cochrane Database of Systematic Reviews. ,(1998) , 10.1002/14651858.CD000953
Pauline M Dowd, MFR Martin, ED Cooke, SALLY A BOWCOCK, R Jones, PA Dieppe, JDT Kirby, None, Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) British Journal of Dermatology. ,vol. 106, pp. 81- 89 ,(1982) , 10.1111/J.1365-2133.1982.TB00905.X
Robert Jackson, None, Raynaud and Molière Archives of Dermatology. ,vol. 119, pp. 263- 266 ,(1983) , 10.1001/ARCHDERM.1983.01650270081022
C.B. Bunker, C. Reavley, P.M. Dowd, D.J. O'Shaughnessy, Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. The Lancet. ,vol. 342, pp. 80- 83 ,(1993) , 10.1016/0140-6736(93)91286-U
PAULINE M. DOWD, The treatment of Raynaud's phenomenon. British Journal of Dermatology. ,vol. 114, pp. 527- 533 ,(1986) , 10.1111/J.1365-2133.1986.TB04059.X
B. Coleiro, S. E. Marshall, C. P. Denton, K. Howell, A. Blann, K. I. Welsh, C. M. Black, Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine Rheumatology. ,vol. 40, pp. 1038- 1043 ,(2001) , 10.1093/RHEUMATOLOGY/40.9.1038
PaulineM. Dowd, PortiaC. Goldsmith, HelenA. Bull, Geoffrey Burnstock, JohnC. Foreman, Ian Marshall, Raynaud's phenomenon The Lancet. ,vol. 346, pp. 283- 290 ,(1995) , 10.1016/S0140-6736(95)92169-9
R. Jackson, Raynaud and Moliere Archives of Dermatology. ,vol. 119, pp. 263- 266 ,(1983) , 10.1001/ARCHDERM.119.3.263